ロード中...
Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden
BACKGROUND: Tumor mutation burden has been proven to be a good predictor for the efficacy of immunotherapy, especially in patients with hypermutation. However, most research focused on the analysis of hypermutation in individual tumors, and there is a lack of integrated research on the hypermutation...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100597/ https://ncbi.nlm.nih.gov/pubmed/33968789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.682017 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|